In this case, we recommend preferential deescalation of therapies that are most likely to cause side effects, hypoglycemia, and/or treatment burden and do not have cardiovascular, kidney, or metabolic benefits for continued use
The diagnosis of atypical KD should be considered in children with prolonged unexplained fever, less than 4 of the AHA criteria, compatible laboratory findings, or concerning echocardiographic findings (such as coronary artery aneurysm or reduced EF) (Figure 4)
A medication producing 24% weight loss means nothing if patients cannot tolerate it long enough to reach those results
This advanced combination brings together antioxidants, amino acids, and essential minerals to support energy production and protect cells from damage
Biosimilar Comparability Method Development Considerations for LC-MS Characterization of GLP-1 Peptides Successful LC-MS Characterization of GLP-1 Peptides requires careful optimization of chromatographic conditions and mass spectrometry parameters
Growth hormone-releasing peptides are so poorly studied, we often do not know how they get metabolized in the body and thus which molecules to look for
